Page last updated: 2024-09-02

11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine

11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine in 1 studies

Compound Research Comparison

Studies
(11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid)
Trials
(11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid)
Recent Studies (post-2010)
(11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid)
Studies
(2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine)
Trials
(2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine)
Recent Studies (post-2010) (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine)
30427103135650

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abou El Hassan, M; Colantonio, D; Likhodii, S; Nassar, BA1

Other Studies

1 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine

ArticleYear
The analytical performance of six urine drug screens on cobas 6000 and ARCHITECT i2000 compared to LC-MS/MS gold standard.
    Clinical biochemistry, 2021, Volume: 93

    Topics: Amphetamine; Chromatography, High Pressure Liquid; Cocaine; Diagnostic Errors; Dronabinol; Humans; Immunoassay; Opiate Alkaloids; Oxycodone; Predictive Value of Tests; Pyrrolidines; Substance Abuse Detection; Tandem Mass Spectrometry

2021